Article Information
History
- April 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sarah A. Buchan, PhD1,2,3,4,
- Lena Nguyen, MSc2,
- Sarah E. Wilson, MD1,2,3,4,
- Sophie A. Kitchen, MSc2 and
- Jeffrey C. Kwong, MD1,2,3,4,5,6,*
- 1Public Health Ontario, Toronto, ON
- 2ICES, Toronto, ON
- 3Dalla Lana School of Public Health, University of Toronto, Toronto, ON
- 4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON
- 5Department of Family and Community Medicine, University of Toronto, Toronto, ON
- 6University Health Network, Toronto, ON
- ↵*Corresponding author: Jeff Kwong, Senior Scientist, ICES, G1 06, 2075 Bayview Avenue, Toronto, Ontario, Canada, M4N 3M5, jeff.kwong{at}utoronto.ca, Phone: (416) 480-4055 x1-7665, Fax: (416) 480-6048
Posted April 07, 2022.
Vaccine effectiveness of BNT162b2 against Omicron and Delta outcomes in adolescents
